Yoshio Sumida
Minato, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 186 publications
Metabolic Burden and Hyperuricemia Are Associated With CKD-Related Outcomes in Individuals With and Without Steatotic Liver Disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 30, 2026
Optimizing VCTE and ELF Thresholds for Treatment-Eligible F2-F3 Fibrosis in Japanese Patients With MASLD.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: December 24, 2025
A case of sclerosing variant of pancreatic neuroendocrine tumour with mucin lakes.
Journal: The Malaysian journal of pathology
Published: December 23, 2025
Steatosis index: a novel multiparametric ultrasound approach for accurate liver steatosis quantification and grading.
Journal: Journal of gastroenterology
Published: December 19, 2025
Impact of cardiometabolic criteria on the pathogenesis of MASLD and diagnostic performance of non-invasive tests.
Journal: Journal of gastroenterology
Published: November 17, 2025
Noninvasive strategies for metabolic dysfunction-associated steatotic liver disease assessment and referral in Japan.
Journal: World journal of gastroenterology
Published: September 11, 2025
Guidance for Liver Rehabilitation in Chronic Liver Disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: September 02, 2025
Sequential Fibrosis-4 Index and Mac-2 Binding Protein Glycosylation Isomer Combination Improve Detection of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Study.
Journal: Gastro hep advances
Published: July 03, 2025
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: June 30, 2025
Impact of Model for End-Stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: May 05, 2025
Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: May 05, 2025
Utilizing Altmetrics to Track Advancements in Noninvasive Tests for MASLD.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 16, 2025
Last Updated: 09/26/2026